This past year has seen various developments in the field of oncolytic virus therapies - in fundraising and in the clinic.

New narcolepsy treatments are being tested in the clinic, and recently, some of them have made promising strides. How far ...

Learn how Deep Science Ventures’ zero-data approach tackles biotech’s early funding challenges to speed innovation and reduce ...

Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.

Get the 2025 update on the biotech companies Labiotech spotlighted in 2024 — who advanced, who stalled, and who surprised us.

NATO Innovation Fund backs Portal Biotech in its first biotech move. What does this signal for strategic investment in ...

XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive industry innovation.

Discover how AI and ML are already shaping therapeutic antibody discovery and explore their future potential.

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article.

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.